Diagnostics crucial to Vietnam malaria successes:
This article was originally published in Clinica
Executive Summary
Early diagnosis is crucial in the fight against malaria, a disease which kills two million people a year worldwide. This is the conclusion of a study conducted in the province of Binh Thuan, in southern Vietnam, where the incidence of malaria has fallen from 42% to 4% over the last five years. The study reported in the August issue of the bulletin of the World Health Organization (WHO), documents the crucial importance of introducing a primary care testing programme to control the disease. The technology available "can be very effective but only if it is used fully and on a continuous basis", said Dr Kamini Mendis, of the WHO's malaria programme. Other basic anti-malarial strategies, such as the introduction of bednets, cannot alone achieve the "rapid decline of malaria" observed since the introduction of the testing, the study concludes.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.